Abstract Details
|
Yoshie Umemura, MD, FAAN
(Ivy Brain Tumor Center at Barrow Neurological Institute)
PRESENTER |
Dr. Umemura has received personal compensation for serving as an employee of Barrow Neurological Institute. Dr. Umemura has received personal compensation for serving as an employee of University of Michigan. Dr. Umemura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Qessential. Dr. Umemura has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Servier. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Honorarium with Curio Science LLC. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Honorarium with OncLive. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Honorarium with MJH Life Sciences. |
| Antonio M. Omuro, MD, FAAN (Stanford University) | Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Telix. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curevac. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Arcus Biosciences. The institution of Dr. Omuro has received research support from Denovo Biopharma. The institution of Dr. Omuro has received research support from Ono Pharmaceutical. The institution of Dr. Omuro has received research support from Servier. The institution of Dr. Omuro has received research support from Nanopharmaceuticals. The institution of Dr. Omuro has received research support from Denovo. |